Bengaluru-based startup Mandrake Bio has raised Rs 16 crore in a funding round co-led by early-stage venture firms Activate, founded by Aakrit Vaish, and Antler India to develop programmable gene-editing enzymes using generative AI.The round also saw participation from Spectrum Impact, DeVC and various angel investors, including biotech veteran Vijay Chandru, entrepreneur Paras Chopra, Sanjiv Rangrass and Vatsal Dusad.
The fresh capital will be used to expand the company's AI and biophysics teams and accelerate “wet-lab” validation of its platform.
